| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 690.10M | 718.20M | 733.80M | 749.20M | 694.50M |
| Gross Profit | 259.00M | 336.50M | 339.50M | 350.20M | 313.20M |
| EBITDA | -18.20M | 135.80M | 141.50M | 154.20M | 123.80M |
| Net Income | -99.80M | 47.50M | -27.70M | 62.70M | 41.20M |
Balance Sheet | |||||
| Total Assets | 1.04B | 1.21B | 1.32B | 1.48B | 1.35B |
| Cash, Cash Equivalents and Short-Term Investments | 32.60M | 61.50M | 76.20M | 101.20M | 92.50M |
| Total Debt | 80.50M | 101.60M | 86.10M | 76.00M | 98.70M |
| Total Liabilities | 277.70M | 306.90M | 328.50M | 334.60M | 336.30M |
| Stockholders Equity | 763.20M | 899.60M | 987.30M | 1.14B | 1.01B |
Cash Flow | |||||
| Free Cash Flow | 61.20M | 32.20M | 67.20M | 96.60M | 61.10M |
| Operating Cash Flow | 64.60M | 75.30M | 107.50M | 126.20M | 84.30M |
| Investing Cash Flow | -20.60M | -17.70M | -71.20M | -43.70M | 23.90M |
| Financing Cash Flow | -71.70M | -67.10M | -56.10M | -81.80M | -65.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £2.18B | 13.52 | 20.41% | 2.58% | 11.42% | -17.18% | |
65 Neutral | £290.73M | 14.12 | 4.06% | 1.52% | 2.12% | 23.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | £249.45M | -2.75 | -17.36% | 1.11% | ― | ― | |
60 Neutral | £345.37M | -0.96 | -12.22% | 15.28% | -3.91% | -310.36% | |
54 Neutral | £358.31M | -45.29 | 0.58% | 2.31% | 10.68% | -89.58% | |
41 Neutral | £377.30M | -0.78 | -142.88% | ― | -7.30% | -311.68% |